Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Return on Assets (2020 - 2025)

Historic Return on Assets for Kymera Therapeutics (KYMR) over the last 6 years, with Q3 2025 value amounting to 0.3%.

  • Kymera Therapeutics' Return on Assets fell 800.0% to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.34% for FY2024, which is 600.0% down from last year.
  • According to the latest figures from Q3 2025, Kymera Therapeutics' Return on Assets is 0.3%, which was down 800.0% from 0.3% recorded in Q2 2025.
  • In the past 5 years, Kymera Therapeutics' Return on Assets registered a high of 0.1% during Q1 2021, and its lowest value of 0.33% during Q3 2023.
  • In the last 5 years, Kymera Therapeutics' Return on Assets had a median value of 0.26% in 2022 and averaged 0.24%.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -1300bps in 2022, then surged by 1100bps in 2024.
  • Kymera Therapeutics' Return on Assets (Quarter) stood at 0.16% in 2021, then crashed by -61bps to 0.26% in 2022, then dropped by -13bps to 0.29% in 2023, then rose by 11bps to 0.26% in 2024, then decreased by -14bps to 0.3% in 2025.
  • Its Return on Assets stands at 0.3% for Q3 2025, versus 0.3% for Q2 2025 and 0.29% for Q1 2025.